ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

New England Medical Center Discloses Case Of Two Overdoses

April 28, 1995

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

NCI Advisory Group, Other Cancer Meetings

February 28, 1986